We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Tools
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Arix Bioscience Plc | LSE:ARIX | London | Ordinary Share | GB00BD045071 | ORD 0.001P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | |
|---|---|---|---|---|---|
| 0.50 | 0.45% | 112.50 | 111.00 | 114.00 |
| High Price | Low Price | Open Price | Shares Traded | Last Trade |
|---|---|---|---|---|
| 113.25 | 112.50 | 112.50 | 387,262 | 08:00:08 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Coml Physical, Biologcl Resh | 112k | -27.58M | -0.2130 | -5.28 | 145.62M |
| Date | Time | Source | Headline |
|---|---|---|---|
| 13/11/2023 | 16:00 | UKREG | Correction: Portfolio Company Aura Biosciences Announces Closing of USD99.. |
| 10/11/2023 | 08:00 | UKREG | Portfolio Company Aura Biosciences Announces Closing of USD99 million.. |
| 10/11/2023 | 07:00 | UKREG | PDMR Notification & Director Shareholding |
| 08/11/2023 | 07:00 | UKREG | Unaudited NAV for October 2023 |
| 03/11/2023 | 16:30 | UKREG | PDMR Notification & Director Shareholding |
| 02/11/2023 | 18:20 | UKREG | PDMR Notification & Director Shareholding |
| 01/11/2023 | 16:30 | UKREG | Portfolio Company Sorriso Pharmaceuticals Announces First Subject Dosed in.. |
| 01/11/2023 | 12:19 | ALNC |  RTW Biotech agrees "immediately accretive" Arix Bioscience takeover |
| 01/11/2023 | 07:06 | UKREG | RTW Biotech Opportunities Ltd RTW Biotech to acquire Arix Bioscience's.. |
| 25/10/2023 | 20:55 | ALNC | TRADING UPDATES: Gran Tierra completes offers, Pensana wins grant |
1 Year Arix Bioscience Chart |
Intraday Arix Bioscience Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
|
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions Support: +44 (0) 203 8794 460 | support@advfn.com |
| ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil |
| ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico |
| ADVFN France ADVFN US ADVFN Korea |
